Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of CardiolRx on Myocardial Recovery in Patients with Acute Myocarditis
2021-006637-19Phase 2Active
- Sponsor
- Cardiol Therapeutics Inc.
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of cannabidiol in acute myocarditis, sponsored by Cardiol Therapeutics Inc. Primary endpoint: Safety endpoint. Started Jul 2024; status: active.
02
Drugs
cannabidiol
03
Conditions
acute myocarditis
Beyond the preview
Go deeper on 2021-006637-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-006637-19.